License Agreements - Additional Information (Details) - License Agreement - USD ($)	1 Months Ended	3 Months Ended	12 Months Ended
	Feb. 28, 2019	Mar. 31, 2025	Dec. 31, 2024	Dec. 31, 2022
Schedule Of License Agreement [Line Items]
Milestone payment				$ 100,000
Written notice period to terminated agreement		60 days
Written notice period to terminated license agreement in event of breach of contract		30 days
Uncured period of agreement in event of breach of agreement notice		60 days
Written notice period for termination of agreement		90 days
Termination period Description		WARF may terminate the License Agreement with 90 days written notice if first commercial sale does not occur before December 31, 2031. Unless terminated earlier by the parties, the term of the License Agreement will continue until the last licensed patent expires in all countries.
Maximum
Schedule Of License Agreement [Line Items]
Potential milestone payments		$ 800,000
Investigation New Drug (IND) | Maximum
Schedule Of License Agreement [Line Items]
Expected milestone payment on achieving certain regulatory and commercial milestones		17,500,000
Investigation New Drug (IND) | Minimum
Schedule Of License Agreement [Line Items]
Expected royalty payments upon first commercial product sale		$ 100,000
Research and Development
Schedule Of License Agreement [Line Items]
Upfront payment upon execution of agreement	$ 300,000
License fees			$ 200,000